Polar Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 1.00 M
as on 13-12-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.26 M
as on 13-12-2024
- Revenue -15.19%
(FY 2023)
- Profit -44.57%
(FY 2023)
- Ebitda -85.66%
(FY 2023)
- Net Worth 32.93%
(FY 2023)
- Total Assets 35.62%
(FY 2023)
About Polar Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.26 M.
Vazrala Reddy and Krishna Kandula serve as directors at the Company.
- CIN/LLPIN
U24299TG2020PTC145050
- Company No.
145050
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Polar Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vazrala Reddy  | Director | 20-Oct-2020 | Current |
| Krishna Kandula | Director | 20-Oct-2020 | Current |
Financial Performance of Polar Biosciences.
Polar Biosciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.19% decrease. The company also saw a substantial fall in profitability, with a 44.57% decrease in profit. The company's net worth Soared by an impressive increase of 32.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polar Biosciences?
Unlock access to Polar Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Aug 2024 | ₹4.78 M | Open |
Hdfc Bank Limited Creation Date: 03 Jul 2021 | ₹2.48 M | Open |
How Many Employees Work at Polar Biosciences?
Polar Biosciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polar Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polar Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
